نتائج البحث

A bibliometric analysis of alternative drug therapy options in the treatment of androgenetic alopecia.

• Authors : Gupta, Aditya K.^1,2 (AUTHOR); Taylor, Daniel¹ (AUTHOR); Ravi, Shruthi Polla¹ (AUTHOR)

• Source: Journal of Cosmetic Dermatology. Oct2024, Vol. 23 Issue 10, p3287-3294. 8p.

تفاصيل العنوان

Patient versus physician preferences for lipid‐lowering drug therapy: A discrete choice experiment.

• Authors : Zhang, Lingli¹; Chen, Jiali²; Cao, Zhaoliu³

• Source: Health Expectations. Apr2024, Vol. 27 Issue 2, p1-13. 13p.

تفاصيل العنوان

The Interplay Between HIF‐1α and EZH2 in Lung Cancer and Dual‐Targeted Drug Therapy.

• Authors : Wang, Jianmin^1,2 (AUTHOR); Yang, Cheng^1,2 (AUTHOR); Xu, Huashen³ (AUTHOR)

• Source: Advanced Science. 2/16/2024, Vol. 11 Issue 7, p1-16. 16p.

تفاصيل العنوان

From drug therapy failures to laser therapy victory: A case report and literature review of lupus miliaris disseminatus faciei resolution.

• Authors : Bazargan, Afsaneh Sadeghzadeh¹ (AUTHOR); Roohaninasab, Masoumeh¹ (AUTHOR); Kahjoogh, Hossein Ahmadi² (AUTHOR)

• Source: Clinical Case Reports. Sep2024, Vol. 12 Issue 9, p1-7. 7p.

تفاصيل العنوان

Combined use of CLP290 and bumetanide alleviates neuropathic pain and its mechanism after spinal cord injury in rats.

• Authors : Pan YZ; Rehabilitation Medicine Department, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.; School of Rehabilitation Medicine, Capital Medical University, Beijing, China.

Subjects: Bumetanide*/Bumetanide*/Bumetanide*/pharmacology ; Bumetanide*/Bumetanide*/Bumetanide*/therapeutic use ; Spinal Cord Injuries*/Spinal Cord Injuries*/Spinal Cord Injuries*/complications

• Source: CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Sep; Vol. 30 (9), pp. e70045.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101473265 Publication Model: Print Cited Medium:

تفاصيل العنوان

Efficacy, safety, and tolerability of adjunctive Lacosamide therapy for focal seizures in young children aged ≥1 month to ≤4 years: A real-world study.

• Authors : Yang L; Department of Neurology Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation base of Child development and Critical Disorders, Chongqing Key Laboratory of Child Neurodevelopment and Cognitive Disorders, Big Data Engineering Center, Children's Hospital of Chongqing Medical University, Chongqing, China.; Liu Y

Subjects: Lacosamide*/Lacosamide*/Lacosamide*/therapeutic use ; Lacosamide*/Lacosamide*/Lacosamide*/administration & dosage ; Lacosamide*/Lacosamide*/Lacosamide*/adverse effects

• Source: CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Aug; Vol. 30 (8), pp. e14917.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101473265 Publication Model: Print Cited Medium:

تفاصيل العنوان

Changes in plasma alpha‐1 acid glycoprotein following hemorrhagic trauma: Possible role in dose differences of ALM drug therapy in rat and pig resuscitation.

• Authors : Letson, Hayley L.¹ (AUTHOR); Morris, Jodie L.¹ (AUTHOR); Dobson, Geoffrey P.¹ (AUTHOR)

• Source: Pharmacology Research & Perspectives. Oct2023, Vol. 11 Issue 5, p1-6. 6p.

تفاصيل العنوان

Vitamin D 3 Attenuates Neuropathic Pain via Suppression of Mitochondria-Associated Ferroptosis by Inhibiting PKCα/NOX4 Signaling Pathway.

• Authors : Zhang W; Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Yu S

Subjects: Cholecalciferol*/Cholecalciferol*/Cholecalciferol*/pharmacology ; Ferroptosis*/Ferroptosis*/Ferroptosis*/drug effects ; Ferroptosis*/Ferroptosis*/Ferroptosis*/physiology

• Source: CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Sep; Vol. 30 (9), pp. e70067.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101473265 Publication Model: Print Cited Medium:

تفاصيل العنوان

High-concentration hydrogen inhalation mitigates sepsis-associated encephalopathy in mice by improving mitochondrial dynamics.

• Authors : Cui Y; Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.; Department of Critical Care Medicine, Tianjin Medical University General Hospital, Tianjin, China.

Subjects: Sepsis-Associated Encephalopathy*/Sepsis-Associated Encephalopathy*/Sepsis-Associated Encephalopathy*/drug therapy ; Hydrogen*/Hydrogen*/Hydrogen*/pharmacology ; Hydrogen*/Hydrogen*/Hydrogen*/administration & dosage

• Source: CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Sep; Vol. 30 (9), pp. e70021.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101473265 Publication Model: Print Cited Medium:

تفاصيل العنوان

A randomized, double-blind, placebo-controlled, dose-escalating phase IIa trial to evaluate the safety, tolerability, efficacy, and pharmacokinetics of multiple oral doses of Pynegabine tablets as add-on therapy in patients with focal epilepsy.

• Authors : Wei S; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing, China.

Subjects: Epilepsies, Partial*/Epilepsies, Partial*/Epilepsies, Partial*/drug therapy ; Anticonvulsants*/Anticonvulsants*/Anticonvulsants*/pharmacokinetics ; Anticonvulsants*/Anticonvulsants*/Anticonvulsants*/administration & dosage

• Source: CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Sep; Vol. 30 (9), pp. e70002.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101473265 Publication Model: Print Cited Medium:

تفاصيل العنوان